NEA adjusts Monte Rosa Therapeutics (GLUE) stake with share distribution and sales

Rhea-AI Filing Summary

Monte Rosa Therapeutics major holder New Enterprise Associates has updated its ownership details. NEA 17 now holds 6,692,298 shares of Monte Rosa common stock, representing 7.9% of the company’s outstanding shares based on 84,479,418 shares outstanding as of May 1, 2026.

On July 1, 2026, NEA 17 made a pro rata distribution of 1,000,000 Monte Rosa shares to its general partner and limited partners for no consideration. NEA Partners 17 briefly received 15,000 shares in this distribution, then distributed those 15,000 shares the same day, including 11,830 shares to an entity for which certain NEA executives may be deemed beneficial owners. Those indirectly received shares were sold on July 2, 2026 as described in Schedule A.

The filing also notes that Ali Behbahani holds options to purchase 135,432 shares exercisable within 60 days, and that several named individuals each ceased to beneficially own 5% or more of Monte Rosa’s common stock as of April 1, 2026.

Key Figures

NEA 17 shares: 6,692,298 shares Ownership percentage: 7.9% Shares outstanding: 84,479,418 shares +5 more

8 metrics

NEA 17 shares 6,692,298 shares Beneficial ownership of Monte Rosa common stock

Ownership percentage 7.9% Percent of Monte Rosa common stock class represented by NEA stake

Shares outstanding 84,479,418 shares Monte Rosa common stock outstanding as of May 1, 2026

Pro rata distribution 1,000,000 shares Shares distributed by NEA 17 on July 1, 2026

NEA Partners 17 distribution 15,000 shares Distributed for no consideration on July 1, 2026

Indirectly received shares 11,830 shares Received by an entity associated with NEA executives, later sold on July 2, 2026

Behbahani option shares 135,432 shares Options exercisable within 60 days as of July 6, 2026

Behbahani ownership percentage 0.2% Percentage of Monte Rosa common stock including option shares

Key Terms

beneficially own, pro rata distribution, sole voting power, shared dispositive power, +2 more

6 terms

beneficially own financial

"may be deemed to beneficially own the NEA 17 Shares"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

pro rata distribution financial

"NEA 17 made a pro rata distribution of 1,000,000 shares"

A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.

sole voting power financial

"Number of Shares Beneficially Owned by Each Reporting Person With: | 7 | Sole Voting Power"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

shared dispositive power financial

"10 | Shared Dispositive Power 6,692,298.00"

percent of class financial

"13Percent of class represented by amount in Row (11) 7.9 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

options to purchase financial

"record owner of options to purchase 135,432 shares of Common Stock"

A legal right, usually in the form of a contract, that lets someone buy a specific asset—most often shares—at a set price within a fixed time period. Think of it like a reservation or coupon that guarantees today’s price for a future purchase; investors watch these because exercising the options can change how many shares exist, affect company ownership, and create potential gains or dilution for existing shareholders.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/06/2026 - 05:52 PM Accepted by SEC EDGAR 07/06/2026 - 05:51 PM Learn about SEC filing dates

FAQ

What ownership stake does NEA 17 report in Monte Rosa Therapeutics (GLUE)?

NEA 17 reports beneficial ownership of 6,692,298 Monte Rosa common shares, representing 7.9% of the company. This percentage is based on 84,479,418 shares outstanding as of May 1, 2026, as disclosed in Monte Rosa’s Form 10-Q.

What transaction did NEA 17 disclose on July 1, 2026 for Monte Rosa (GLUE)?

On July 1, 2026, NEA 17 made a pro rata distribution of 1,000,000 Monte Rosa shares to its general partner and limited partners for no consideration. NEA Partners 17 then received and redistributed 15,000 shares as part of this internal restructuring.

How many Monte Rosa (GLUE) shares did NEA executives indirectly receive and sell?

An entity for which certain NEA executives may be deemed beneficial owners received 11,830 Monte Rosa shares in the July 1, 2026 distribution. These indirectly received shares were sold on July 2, 2026, with specific sale details provided in Schedule A of the filing.

What is Ali Behbahani’s reported position in Monte Rosa Therapeutics (GLUE)?

As of July 6, 2026, Ali Behbahani is the record owner of options to purchase 135,432 Monte Rosa common shares exercisable within 60 days. This position represents 0.2% of the company when added to the outstanding share count used in the filing’s calculations.

Which Monte Rosa (GLUE) holders fell below the 5% ownership threshold?

The filing states that as of April 1, 2026, Forest Baskett, Ali Behbahani, Carmen Chang, Edward T. Mathers, Paul Walker and Rick Yang each ceased to beneficially own five percent or more of Monte Rosa’s outstanding common stock.

How did the filing calculate NEA’s percentage ownership in Monte Rosa (GLUE)?

The reported 7.9% beneficial ownership for NEA 17 and related reporting persons is based on 84,479,418 Monte Rosa common shares outstanding as of May 1, 2026, as disclosed in the company’s Form 10-Q filed on May 7, 2026.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)

Monte Rosa Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

61225M102

(CUSIP Number)

Stephanie Brecher
New Enterprise Associates, 1954 Greenspring Drive, Suite 600
Timonium, MD, 21093
(410)842-4000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

07/01/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

New Enterprise Associates 17, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

WC

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

NEA Partners 17, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

NEA 17 GP, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Anthony A. Florence, Jr.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Mohamad H. Makhzoumi

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Scott D. Sandell

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,692,298.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,692,298.00

11

Aggregate amount beneficially owned by each reporting person

6,692,298.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

7.9 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Forest Baskett

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Ali Behbahani

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 135,432.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 135,432.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

135,432.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Carmen Chang

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Edward T. Mathers

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Paul Walker

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 61225M102

1

Name of reporting person

Rick Yang

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.00 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $0.0001 per share
(b)	Name of Issuer: Monte Rosa Therapeutics, Inc.
(c)	Address of Issuer's Principal Executive Offices: 321 Harrison Avenue, Suite 900, Boston, MASSACHUSETTS , 02118.
Item 1 Comment: This Amendment No. 4 ("Amendment No. 4") to Schedule 13D amends and supplements the Schedule 13D originally filed on July 12, 2021 (the "Schedule 13D"), Amendment No. 1 thereto filed on May 13, 2024 ("Amendment No. 1"), Amendment No. 2 thereto filed on August 12, 2024 ("Amendment No. 2") and Amendment No. 3 thereto filed on March 19, 2026 ("Amendment No. 3") relating to the Common Stock of the Issuer. Certain terms used but not defined in this Amendment No. 4 have the meanings assigned thereto in the Schedule 13D (and Amendment No. 1, Amendment No. 2 and Amendment No. 3 thereto). Except as specifically provided herein, this Amendment No. 4 does not modify any of the information previously reported on the Schedule 13D (and Amendment No. 1, Amendment No. 2 and Amendment No. 3 thereto).
Item 2.	Identity and Background
(a)	New Enterprise Associates 17, L.P. ("NEA 17"); NEA Partners 17, L.P. ("NEA Partners 17"), which is the sole general partner of NEA 17; and NEA 17 GP, LLC ("NEA 17 LLC" and, together with NEA Partners 17, the "Control Entities"), which is the sole general partner of NEA Partners 17; Anthony A. Florence, Jr. ("Florence"), Mohamad H. Makhzoumi ("Makhzoumi") and Scott D. Sandell ("Sandell"); and Forest Baskett ("Baskett"), Ali Behbahani ("Behbahani"), Carmen Chang ("Chang"), Edward T. Mathers ("Mathers"), Paul Walker ("Walker") and Rick Yang ("Yang"). Florence, Makhzoumi and Sandell are each a member of the Executive Committee of NEA Management Company, LLC (the "Executive Committee"). The persons named in this Item 2 are referred to individually herein as "Reporting Person" and collectively as the "Reporting Persons."
(b)	The address of the principal business office of NEA 17, each Control Entity and Sandell is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Makhzoumi is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, CA 94025. The address of the principal business office of Florence is New Enterprise Associates, 104 5th Avenue, 19th Floor, New York, NY 10011.
(c)	The principal business of NEA 17 is to invest in and assist growth-oriented businesses located principally in the United States. The principal business of NEA Partners 17 is to act as the sole general partner of NEA 17. The principal business of NEA 17 LLC is to act as the sole general partner of NEA Partners 17. The principal business of each of the Florence, Makhzoumi and Sandell is to manage the Control Entities, NEA 17 and a number of affiliated partnerships with similar businesses.
(d)	During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(e)	During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	NEA 17 LLC is a limited liability company organized under the laws of the State of Delaware. NEA 17 and NEA Partners 17 are limited partnerships organized under the laws of the State of Delaware. Florence, Makhzoumi and Sandell are each a United States citizen.
Item 3.	Source and Amount of Funds or Other Consideration
	Not applicable.
Item 4.	Purpose of Transaction
	The information provided in Item 5(c) is hereby incorporated by reference. Depending on market conditions and other factors, NEA 17 and the Reporting Persons may dispose of additional shares of the Issuer.
Item 5.	Interest in Securities of the Issuer
(a)	NEA 17 is the record owner of the NEA 17 Shares. As the general partner of NEA 17, NEA Partners 17 may be deemed to own beneficially the NEA 17 Shares. As the sole general partner of NEA Partners 17, NEA 17 LLC may be deemed to beneficially own the NEA 17 Shares. As individual members of the Executive Committee, which committee has voting and dispositive power with respect to the NEA 17 Shares, each of Florence, Makhzoumi and Sandell may be deemed to beneficially own the NEA 17 Shares. Each Reporting Person disclaims beneficial ownership of the NEA 17 Shares other than those shares which such person owns of record. As of July 6, 2026, Behbahani is the record owner of options to purchase 135,432 shares of Common Stock exercisable within 60 days (the "Behbahani Option Shares"). The percentage of outstanding Common Stock of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on the 84,479,418 shares of Common Stock reported by the Issuer to be outstanding as of May 1, 2026, as reported on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026. The percentage set forth on the cover sheet for Behbahani is calculated based on the shares described in the preceding sentence plus the Behbahani Option Shares.
(b)	Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets (ii) shared power to vote or to direct the vote: See line 8 of cover sheets (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets.
(c)	On July 1, 2026, NEA 17 made a pro rata distribution of 1,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners for no consideration (the "NEA 17 Distribution"). NEA Partners 17 acquired 15,000 shares of Common Stock of the Issuer as a result of the NEA 17 Distribution and, subsequent to the NEA 17 Distribution, on July 1, 2026, made a distribution of 15,000 shares of Common Stock of the Issuer for no consideration (the "NEA Partners 17 Distribution"), of which 11,830 shares were received by an entity for which Florence, Makhzoumi and Sandell may be deemed to have beneficial ownership. NEA 17 now holds a total of 6,692,298 shares of Common Stock of the Issuer (the "NEA 17 Shares"). On July 2, 2026, the shares indirectly received by Florence, Makhzoumi and Sandell in the NEA Partners 17 Distribution were sold as set forth on Schedule A. No other transactions in the Issuer's Common Stock were effected by the Reporting Persons since the filing of Amendment No. 3.
(d)	No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, Common Stock beneficially owned by any of the Reporting Persons.
(e)	As of April 1, 2026, each of Baskett, Behbahani, Chang, Mathers, Walker and Yang has ceased to beneficially own five percent (5%) or more of the Issuer's Common Stock.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Not applicable.
Item 7.	Material to be Filed as Exhibits.
	Exhibit 1 - Agreement regarding filing of joint Schedule 13D. Exhibit 2 - Schedule A: Transactions. Exhibit 3 - Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

New Enterprise Associates 17, L.P.

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Co-Chief Executive Officer
Date:	07/06/2026

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Co-Chief Executive Officer
Date:	07/06/2026

NEA Partners 17, L.P.

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Co-Chief Executive Officer
Date:	07/06/2026

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Co-Chief Executive Officer
Date:	07/06/2026

NEA 17 GP, LLC

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Co-Chief Executive Officer
Date:	07/06/2026

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi, Co-Chief Executive Officer
Date:	07/06/2026

Anthony A. Florence, Jr.

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Anthony A. Florence, Jr.
Date:	07/06/2026

Mohamad H. Makhzoumi

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi
Date:	07/06/2026

Scott D. Sandell

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Scott D. Sandell
Date:	07/06/2026

Forest Baskett

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Forest Baskett
Date:	07/06/2026

Ali Behbahani

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Ali Behbahani
Date:	07/06/2026

Carmen Chang

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Carmen Chang
Date:	07/06/2026

Edward T. Mathers

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Edward T. Mathers
Date:	07/06/2026

Paul Walker

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Paul Walker
Date:	07/06/2026

Rick Yang

Signature:	/s/ Zachary Bambach
Name/Title:	Zachary Bambach as attorney-in-fact for Rick Yang
Date:	07/06/2026

Comments accompanying signature:

This Amendment No. 4 to Schedule 13D was executed by Zachary Bambach on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 3.